MetLife Investment Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$574K Buy
91,110
+2,078
+2% +$13.1K ﹤0.01% 1609
2025
Q1
$571K Sell
89,032
-4,415
-5% -$28.3K ﹤0.01% 1664
2024
Q4
$751K Buy
93,447
+11,725
+14% +$94.3K ﹤0.01% 1569
2024
Q3
$1.03M Hold
81,722
0.01% 1372
2024
Q2
$1.03M Buy
81,722
+23,225
+40% +$294K 0.01% 1331
2024
Q1
$280K Buy
58,497
+12,479
+27% +$59.7K ﹤0.01% 1997
2023
Q4
$221K Hold
46,018
﹤0.01% 2189
2023
Q3
$333K Hold
46,018
﹤0.01% 1878
2023
Q2
$342K Buy
46,018
+40,816
+785% +$303K ﹤0.01% 1942
2023
Q1
$36.1K Buy
5,202
+485
+10% +$3.36K ﹤0.01% 2738
2022
Q4
$48.5K Sell
4,717
-124
-3% -$1.28K ﹤0.01% 2765
2022
Q3
$88.1K Buy
4,841
+3
+0.1% +$55 ﹤0.01% 2711
2022
Q2
$249K Sell
4,838
-39
-0.8% -$2.01K ﹤0.01% 2160
2022
Q1
$359K Buy
+4,877
New +$359K ﹤0.01% 1985
2021
Q2
Sell
-22,592
Closed -$4.1M 2470
2021
Q1
$4.1M Sell
22,592
-1,954
-8% -$354K 0.04% 494
2020
Q4
$2.74M Sell
24,546
-1,077
-4% -$120K 0.03% 671
2020
Q3
$2.78M Hold
25,623
0.03% 574
2020
Q2
$2.14M Buy
25,623
+10,828
+73% +$903K 0.02% 686
2020
Q1
$201K Buy
+14,795
New +$201K ﹤0.01% 1694
2019
Q1
Sell
-9,069
Closed -$334K 2584
2018
Q4
$334K Hold
9,069
﹤0.01% 1613
2018
Q3
$341K Sell
9,069
-237
-3% -$8.91K ﹤0.01% 1777
2018
Q2
$249K Buy
9,306
+2,368
+34% +$63.4K ﹤0.01% 1818
2018
Q1
$291K Hold
6,938
﹤0.01% 1687
2017
Q4
$172K Buy
+6,938
New +$172K ﹤0.01% 2006